Hedge Fund - Viking Global
Bridgebio Pharma Inc. (BBIO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $1,014,134,407 | 3.71% | 25,120,991 | $30.03 |
| 2 | 2023 - Q3 (2023-09-30) | $662,440,533 | 2.68% | 25,120,991 | $28.38 |
| 3 | 2023 - Q2 (2023-06-30) | $457,881,045 | 1.87% | 26,620,991 | $15.05 |
| 4 | 2023 - Q1 (2023-03-31) | $441,376,031 | 2.07% | 26,620,991 | $11.66 |
| 5 | 2022 - Q4 (2022-12-31) | $202,851,951 | 1.01% | 26,620,991 | $9.57 |
| 6 | 2022 - Q3 (2022-09-30) | $264,613,000 | 1.22% | 26,620,991 | $10.39 |
| 7 | 2022 - Q2 (2022-06-30) | $241,719,000 | 1.1% | 26,620,991 | $8.36 |
| 8 | 2022 - Q1 (2022-03-31) | $270,203,000 | 1.09% | 26,620,991 | $10.26 |
| 9 | 2021 - Q4 (2021-12-31) | $444,038,000 | 1.27% | 26,620,991 | $42.31 |
| 10 | 2021 - Q3 (2021-09-30) | $1,247,726,000 | 3.42% | 26,620,991 | $53.60 |
| 11 | 2021 - Q2 (2021-06-30) | $1,622,816,000 | 4.92% | 26,620,991 | $57.11 |
| 12 | 2021 - Q1 (2021-03-31) | $1,639,853,000 | 4.88% | 26,620,991 | $65.42 |
| 13 | 2020 - Q4 (2020-12-31) | $1,893,019,000 | 5.2% | 26,620,991 | $48.24 |
| 14 | 2020 - Q3 (2020-09-30) | $998,820,000 | 3.6% | 26,620,991 | $31.46 |
| 15 | 2020 - Q2 (2020-06-30) | $868,111,000 | 3.75% | 26,620,991 | $30.46 |
| 16 | 2020 - Q1 (2020-03-31) | $772,009,000 | 4.01% | 26,620,991 | $31.01 |
| 17 | 2019 - Q4 (2019-12-31) | $933,066,000 | 4.37% | 26,620,991 | $27.72 |
| 18 | 2019 - Q3 (2019-09-30) | $571,553,000 | 2.97% | 26,620,991 | $27.66 |
| 19 | 2019 - Q2 (2019-06-30) | $717,968,000 | 3.22% | 26,620,991 | $27.26 |
The displayed share prices are average quarterly stock market prices.